⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28369845 | 0.97 | — | — | |
| SCHEMBL7570146 | 0.81 | — | — | |
| SCHEMBL8906864 | 0.79 | — | — | |
| SCHEMBL486285 | 0.70 | — | — | |
| SCHEMBL13778745 | 0.70 | — | — | |
| SCHEMBL28167120 | 0.69 | — | — | |
| SCHEMBL30089803 | 0.67 | — | — | |
| SCHEMBL1883918 | 0.65 | THRB (0.44) | — | |
| SCHEMBL9386517 | 0.63 | — | — | |
| SCHEMBL31181969 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119859229-B | Preparation method of porous material for removing organic compounds from gas | 山东石油化工学院 | 2025-06-13 | — | — | CN | claimed |
| CN-119859229-A | Preparation method of porous material for removing organic compounds from gas | 山东石油化工学院 | 2025-04-22 | — | — | CN | claimed |
| CN-118619960-A | Application of ligand catalyst in synthesizing indole alkaloid | 浙江九洲药业股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-111377917-B | Heterocyclic compound, intermediate, preparation method and application thereof | 武汉朗来科技发展有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-115003296-A | Compounds and methods for treating cystic fibrosis | 弗拉特利发现实验室有限责任公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-111039915-B | Raf kinase inhibitor, preparation method, pharmaceutical composition and application thereof | 北京鑫开元医药科技有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-113272301-A | Heterocyclic compound, intermediate, preparation method and application thereof | 武汉朗来科技发展有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-108689996-B | Azacyclobutylcarboxamide derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-111377917-A | Heterocyclic compound, intermediate, preparation method and application thereof | 武汉朗来科技发展有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-110054627-B | Novel IDO inhibitor, preparation method, pharmaceutical composition and application thereof | 北京华氏开元医药科技有限公司 | 2020-06-30 | — | — | CN | disclosed |
| CN-111039915-A | Raf kinase inhibitor, preparation method, pharmaceutical composition and application thereof | 北京鑫开元医药科技有限公司 | 2020-04-21 | — | — | CN | disclosed |
| CN-105209490-A | Methods and compositions for delivery of MRNA-encoded antibodies | SHIRE HUMAN GENETIC THERAPIES | 2015-12-30 | — | — | CN | disclosed |
| EP-2892527-A1 | HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS | AbbVie Inc. (US) | 2015-07-15 | — | — | EP | disclosed |
| WO-2014039757-A1 | HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS | ABBVIE INC. (US) | 2014-03-13 | — | — | WO | disclosed |
| CN-103159748-A | Preparation and application of 2-(1H-1, 2, 3-triazole-4-group) aniline compounds | TIANJIN INT JOINT ACADEMY BIOTECHNOLOGY & MEDICINE | 2013-06-19 | — | — | CN | disclosed |
| CN-101591327-B | Benzene alkyl amides compound and usage thereof | UNIV EAST CHINA SCIENCE & TECH | 2012-07-25 | — | — | CN | disclosed |
| CN-101591327-A | Benzene alkyl amides compound and uses thereof | UNIV EAST CHINA SCIENCE & TECH (CN) | 2009-12-02 | — | — | CN | disclosed |
| CN-1075668-A | Process for preparing sintered shapes reaches wherein compositions for use | LUBRIZOL CORP (US) | 1993-09-01 | — | — | CN | disclosed |
| US-4808603-A | HYPOTENSIVE, VASODILATION AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
| EP-0214094-A1 | 1,4-Dihydropyridine derivatives | CIBA-GEIGY AG (CH) | 1987-03-11 | — | — | EP | disclosed |